Li Dean Y — SEC insider filings

SEC reporting owner CIK 1837016. 53 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers the 50 most recent of 53 filings on record, filed 2021-05-04 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Merck & Co., Inc. (MRK)Executive VP & President, MRL19—3 legs · 40,024 sh · $4,839,75138
RECURSION PHARMACEUTICALS, INC. (RXRX)Director31—8 legs · 83,100 sh · $1,491,76832

Insider filings — Li Dean Y

FiledFormIssuerReported transactionsSource
2026-10-024RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 3,378 @ $0EDGAR
2026-07-024RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 3,747 @ $0EDGAR
2026-06-224RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 88,424 @ $0EDGAR
2026-05-074Merck & Co., Inc. (MRK)Grant/award (A): 19,885 (derivative) @ $0 · Grant/award (A): 58,207 (derivative) @ $0EDGAR
2026-05-014Merck & Co., Inc. (MRK)Option exercise (M): 4,722 @ $110.03 · Tax withholding (F): 2,326 @ $110.03 · Option exercise (M): 4,722 (derivative) @ $0EDGAR
2026-04-024RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 3,268 @ $0EDGAR
2026-02-104Merck & Co., Inc. (MRK)Sale (S): 10,235 @ $117.52EDGAR
2026-02-064Merck & Co., Inc. (MRK)Option exercise (M): 15,087 @ $56.04 · Sale (S): 15,087 @ $118.77 · Option exercise (M): 15,087 (derivative) @ $0EDGAR
2026-01-284Merck & Co., Inc. (MRK)Grant/award (A): 20,469 @ $107.40EDGAR
2026-01-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 2,381 @ $0EDGAR
2025-10-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,961 @ $0EDGAR
2025-07-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,949 @ $0EDGAR
2025-06-234RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 22,016 @ $0 · Grant/award (A): 44,031 (derivative) @ $0EDGAR
2025-05-014Merck & Co., Inc. (MRK)Grant/award (A): 14,166 (derivative) @ $0 · Grant/award (A): 64,481 (derivative) @ $0EDGAR
2025-04-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 2,268 @ $0EDGAR
2025-01-294Merck & Co., Inc. (MRK)Grant/award (A): 32,621 @ $97.94EDGAR
2025-01-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,647 @ $0EDGAR
2024-10-044RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,925 @ $0EDGAR
2024-07-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,592 @ $0EDGAR
2024-06-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 13,097 @ $0 · Grant/award (A): 26,193 (derivative) @ $0EDGAR
2024-05-024Merck & Co., Inc. (MRK)Grant/award (A): 65,625 (derivative) @ $0EDGAR
2024-04-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,267 @ $0EDGAR
2024-02-124Merck & Co., Inc. (MRK)Option exercise (M): 14,702 @ $62.07 · Sale (S): 14,702 @ $125.50 · Option exercise (M): 14,702 (derivative) @ $0EDGAR
2024-01-244Merck & Co., Inc. (MRK)Grant/award (A): 25,760 @ $119.43EDGAR
2024-01-114RECURSION PHARMACEUTICALS, INC. (RXRX)Sale (S): 28,038 @ $13.65 · Sale (S): 962 @ $14.03EDGAR
2024-01-044RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,203 @ $0EDGAR
2023-10-044RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,659 @ $0 · Gift (G): 627,705 @ $0EDGAR
2023-07-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,609 @ $0EDGAR
2023-06-214RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 12,612 @ $0 · Grant/award (A): 25,224 (derivative) @ $0EDGAR
2023-05-044Merck & Co., Inc. (MRK)Grant/award (A): 77,455 (derivative) @ $0EDGAR
2023-05-034Merck & Co., Inc. (MRK)Option exercise (M): 1,062 @ $115.47 · Tax withholding (F): 524 @ $115.47 · Option exercise (M): 1,062 (derivative) @ $0EDGAR
2023-04-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,724 @ $0EDGAR
2023-01-254Merck & Co., Inc. (MRK)Grant/award (A): 3,275 @ $109.88EDGAR
2023-01-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,573 @ $0EDGAR
2022-10-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,092 @ $0EDGAR
2022-07-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,409 @ $0EDGAR
2022-06-164RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 18,145 @ $0 · Grant/award (A): 36,290 (derivative) @ $0EDGAR
2022-05-054Merck & Co., Inc. (MRK)Grant/award (A): 75,728 (derivative) @ $0EDGAR
2022-05-044Merck & Co., Inc. (MRK)Option exercise (M): 773 @ $87.65 · Tax withholding (F): 381 @ $87.65 · Option exercise (M): 773 (derivative) @ $0EDGAR
2022-05-034Merck & Co., Inc. (MRK)Option exercise (M): 1,061 @ $88.69 · Tax withholding (F): 523 @ $88.69 · Option exercise (M): 1,061 (derivative) @ $0EDGAR
2022-04-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,544 @ $0EDGAR
2022-02-284Merck & Co., Inc. (MRK)Grant/award (A): 3,023 @ $73.51EDGAR
2022-01-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 659 @ $0EDGAR
2021-12-094/ARECURSION PHARMACEUTICALS, INC. (RXRX)Sale (S): 5,626 @ $20.04 · Sale (S): 13,474 @ $20.20EDGAR
2021-12-094RECURSION PHARMACEUTICALS, INC. (RXRX)Sale (S): 14,900 @ $20.44 · Sale (S): 1,000 @ $21.06EDGAR
2021-11-194RECURSION PHARMACEUTICALS, INC. (RXRX)Sale (S): 5,626 @ $20.04 · Sale (S): 13,474 @ $20.20EDGAR
2021-10-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 543 @ $0EDGAR
2021-07-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 330 @ $0EDGAR
2021-05-064Merck & Co., Inc. (MRK)Option exercise (M): 694 @ $75.98 · Tax withholding (F): 238 @ $75.98 · Grant/award (A): 91,837 (derivative) @ $0 · Option exercise (M): 694 (derivative) @ $0EDGAR
2021-05-044Merck & Co., Inc. (MRK)Option exercise (M): 1,030 @ $74.50 · Tax withholding (F): 354 @ $74.50 · Option exercise (M): 750 @ $74.50 · Tax withholding (F): 257 @ $74.50 · Option exercise (M): 1,030 (derivative) @ $0 · Option exercise (M): 750 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-02-25 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1837016 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs